SAPAN urges the FDA to recognize 'Hallucination of Affect' as an adverse event, warning that unregulated simulated empathy creates dangerous dependency in patients.
SAPAN strengthens governance, standards, and public literacy to prevent digital suffering and prepare institutions for welfare-relevant AI systems.
Latest news on the impacts of artificial sentience readiness and AI welfare
SAPAN urges the FDA to recognize 'Hallucination of Affect' as an adverse event, warning that unregulated simulated empathy creates dangerous dependency in patients.
SAPAN calls on the UN Secretary-General to appoint a digital welfare expert to the new Independent International Scientific Panel on AI.
SAPAN asks NIH and NSF for records on ethics guardrails and oversight; will publish findings for policymakers and the public.
SAPAN provides input to the US AI Action Plan, urging strategic foresight on potential AI sentience to ensure sustainable American leadership and manage future risks....
Groundbreaking platform empowers users to shape the future of AI ethics through direct action and community engagement.
SAPAN advocates for inclusion of artificial sentience considerations in Canada's new AI safety framework.
SAPAN calls for proactive integration of artificial sentience considerations in global AI safety frameworks.
SAPAN calls for legal leadership on AI sentience, citing complexities rivaling the abortion debate.